| Financial Year |
March 31 2023 |
| Monetary Funds |
791,534,594.39 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,534,109.48 |
| Accounts Receivable |
714,917,268.74 |
| Advances to Suppliers |
21,122,884.86 |
| Other Receivables |
58,778,811.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
148,169,838.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,999,270.54 |
| Total Current Assets |
1,896,861,749.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
518,241,439.50 |
| Investment Properties |
18,814,362.78 |
| Fixed Assetes |
1,026,450,014.76 |
| Under-construction Projects |
290,962,916.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,646,556,394.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,923,687.13 |
| Deferred Income Tax Assets |
37,261,164.30 |
| Other Non-Current Assets |
28,139,746.15 |
| Sub-Total of Non-Current Assets |
4,623,787,474.61 |
| Total Assets |
6,520,649,223.69 |
| Short-Term Loans |
236,558,288.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
68,234,432.67 |
| Accounts Payable |
465,783,583.26 |
| Accounts Received In Advance |
773,659.10 |
| Employee Compensation Payable |
7,738,558.70 |
| Taxes Payable |
11,349,913.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
196,249,381.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
265,183,381.45 |
| Other Current Liabilities |
1,242,111.16 |
| Sub-Total of Current Liabilities |
1,268,488,511.24 |
| Long-term Loans |
1,362,084,001.41 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
213,078,167.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
119,128,204.31 |
| Deferred Income Tax Liabilities |
473,883.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,823,824,297.16 |
| Total Liabilities |
3,092,312,808.40 |
| Paid-In Capital(Or Share Stock) |
866,585,766.00 |
| Capital Surplus |
1,462,669,865.94 |
| Surplus Reserve |
101,049,753.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
603,162,135.59 |
| Minority Stockholder's Interest |
382,262,377.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,046,074,037.98 |
| Owner's Equity（Stockholder's Equity） |
3,428,336,415.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,520,649,223.69 |
